What is Northland Capmk’s Estimate for Enovix Q1 Earnings?

Enovix Co. (NASDAQ:ENVX) – Equities researchers at Northland Capmk issued their Q1 2026 earnings per share (EPS) estimates for shares of Enovix in a research note issued on Thursday, February 20th. Northland Capmk analyst G. Richard anticipates that the company will post earnings per share of ($0.27) for the quarter. The consensus estimate for Enovix’s current full-year earnings is ($1.01) per share. Northland Capmk also issued estimates for Enovix’s Q2 2026 earnings at ($0.27) EPS, Q3 2026 earnings at ($0.27) EPS and Q4 2026 earnings at ($0.27) EPS.

ENVX has been the topic of a number of other research reports. Benchmark reiterated a “buy” rating and issued a $25.00 target price on shares of Enovix in a report on Wednesday, October 30th. Craig Hallum reduced their price objective on Enovix from $20.00 to $18.00 and set a “buy” rating on the stock in a research note on Thursday. Cantor Fitzgerald reissued an “overweight” rating and set a $30.00 target price on shares of Enovix in a research report on Thursday. Finally, Janney Montgomery Scott cut shares of Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price target on the stock. in a research report on Thursday, October 31st. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $20.30.

Enovix Stock Performance

Shares of ENVX opened at $10.72 on Monday. The company has a 50-day moving average of $11.15 and a two-hundred day moving average of $10.29. The stock has a market cap of $1.91 billion, a P/E ratio of -7.39 and a beta of 1.87. Enovix has a 12-month low of $5.70 and a 12-month high of $18.68. The company has a current ratio of 3.77, a quick ratio of 3.61 and a debt-to-equity ratio of 0.99.

Enovix (NASDAQ:ENVX) last released its earnings results on Wednesday, February 19th. The company reported ($0.17) EPS for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.01. Enovix had a negative return on equity of 96.99% and a negative net margin of 963.17%. The company had revenue of $9.72 million during the quarter, compared to the consensus estimate of $8.77 million.

Insider Buying and Selling at Enovix

In related news, Director Betsy S. Atkins sold 75,000 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $9.73, for a total transaction of $729,750.00. Following the transaction, the director now directly owns 99,497 shares of the company’s stock, valued at $968,105.81. This trade represents a 42.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 15.70% of the company’s stock.

Institutional Investors Weigh In On Enovix

Large investors have recently modified their holdings of the stock. PharVision Advisers LLC bought a new stake in Enovix during the 4th quarter worth approximately $149,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Enovix by 23.2% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 302,347 shares of the company’s stock valued at $3,287,000 after acquiring an additional 56,986 shares during the period. Two Sigma Investments LP grew its position in Enovix by 910.3% during the 4th quarter. Two Sigma Investments LP now owns 151,770 shares of the company’s stock valued at $1,650,000 after purchasing an additional 136,747 shares during the last quarter. Tidal Investments LLC boosted its holdings in shares of Enovix by 26.2% during the 4th quarter. Tidal Investments LLC now owns 63,670 shares of the company’s stock valued at $692,000 after acquiring an additional 13,232 shares during the last quarter. Finally, Shay Capital LLC bought a new position in shares of Enovix in the 4th quarter worth approximately $124,000. Hedge funds and other institutional investors own 50.92% of the company’s stock.

About Enovix

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.